230 results
8-K
EX-99.1
CORT
Corcept Therapeutics Inc
1 May 24
Corcept Therapeutics Announces First Quarter Financial Results
4:09pm
to obtain acceptable prices and adequate insurance coverage and reimbursement for Korlym; risks related to the development of relacorilant
8-K
EX-99.1
t93l3xf tme3imoac
15 Feb 24
Corcept Therapeutics Announces Fourth Quarter Financial Results
4:11pm
8-K
EX-99.1
2jb 91vz4v
8 Jan 24
Corcept Therapeutics Provides Financial Update
8:06am
8-K
EX-99.1
t78 ecrlybo2luaafz
1 Nov 23
Corcept Therapeutics Announces Third Quarter Financial Results
4:13pm
8-K
EX-99.1
4ztv kk00oj7j3
2 Aug 23
Corcept Therapeutics Announces Second Quarter Financial Results
4:09pm
8-K
EX-99.1
ufi5pnls1gc im1i92m8
3 May 23
Corcept Therapeutics Announces First Quarter Financial Results
4:13pm
8-K
EX-99.1
xshrn8xe
3 Nov 22
Corcept Therapeutics Announces Third Quarter Financial Results
4:09pm